Dublin, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The "Molecular Quality Controls Market by Product (Independent, Instrument Specific), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market

The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period.

The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, an increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.

The infectious diseases segment held the largest share of the molecular controls market in 2018.

Based on application, the molecular controls market is divided into four major segments - infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018. The large share of this segment is attributed to the development of advanced assays for different infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.

Asia Pacific projected to grow at the highest CAGR during the forecast period.

The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary
3.1 Introduction

4 Premium Insights
4.1 Molecular Quality Controls: Market Overview
4.2 Molecular Quality Controls Market, By Product
4.3 North America: Molecular Quality Controls Market, By End User (2018)

5 Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Increasing Number of Accredited Clinical Laboratories
5.1.1.2 Growing Adoption of Third-Party Quality Controls
5.1.1.3 Rising Demand for External Quality Assessment Support
5.1.2 Restraints
5.1.2.1 Additional Costs Involved in Quality Control and Budget Constraints in Hospitals and Laboratories
5.1.2.2 Unfavorable Reimbursement Scenario for Molecular Tests
5.1.3 Opportunities
5.1.3.1 Rising Demand for Multi-Analyte Controls
5.1.4 Challenges
5.1.4.1 Lack of Mandatory Regulations for Clinical Laboratory Accreditation in Several Emerging Countries
5.1.4.2 Complex Regulatory Frameworks

6 Molecular Quality Controls Market, By Product
6.1 Introduction
6.2 Independent Controls
6.2.1 Wide Range of Applications and Reductions in Operational Costs Have Boosted the Use of Independent Controls
6.3 Instrument-Specific Controls
6.3.1 PCR
6.3.1.1 PCR Controls Dominate the Instrument-Specific Controls Market
6.3.2 Dna Sequencing & NGS
6.3.2.1 Advancements in Sequencing Technologies Form A Positive Growth Factor for This Market
6.3.3 Other Technologies

7 Molecular Quality Controls Market, By Analyte Type
7.1 Introduction
7.2 Single-Analyte Controls
7.2.1 Significant Use of Singleplex Assays in Hospitals - A Key Market Driver
7.3 Multi-Analyte Controls
7.3.1 Increasing Preference for Multi-Analyte Controls to Fuel Market Growth

8 Molecular Quality Controls Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 Demand for Infectious Disease Testing Controls has Grown Steadily
8.3 Oncology
8.3.1 Growing Cancer Prevalence and Technological Advancements are Key Growth Drivers in This Segment
8.4 Genetic Testing
8.4.1 Advancements in Genetic Testing Drive the Market
8.5 Other Applications

9 Molecular Quality Controls Market, By End User
9.1 Introduction
9.2 Clinical Laboratories
9.2.1 Increasing Number of Accredited Clinical Laboratories to Provide Growth Opportunities in the Coming Years
9.3 Hospitals
9.3.1 Growing Patient Volume Driving the Adoption of Molecular Quality Controls in Hospital-Based Laboratories
9.4 IVD Manufacturers and Contract Research Organizations
9.4.1 Advancements in Molecular Technologies Driving the Adoption of Molecular Quality Controls Among IVD Manufacturers and Contract Research Organizations
9.5 Academic & Research Institutes
9.5.1 Increasing Demand for Ensuring the Accuracy of Diagnostic Tests to Support the Growth of This End-User Segment
9.6 Other End Users

10 Molecular Quality Controls Market, By Region

11 Competitive Landscape
11.1 Market Overview
11.2 Market Ranking Analysis, 2017
11.3 Competitive Benchmarking

12 Company Profiles
12.1 Seracare Life Sciences Inc.
12.2 Thermo Fisher Scientific
12.3 Bio-Rad Laboratories
12.4 Microbiologics Inc.
12.5 Zeptometrix
12.6 Roche Diagnostics
12.7 Abbott Laboratories
12.8 Quidel
12.9 Qnostics
12.10 Maine Molecular Quality Controls Inc.

For more information about this report visit https://www.researchandmarkets.com/research/jqd7vk/molecular_quality?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics